Lantern Pharma Inc (LTRN)
Insider transactions
A complete record of Form 4 filings tracking every share acquisition and disposal by executives, directors, and senior officers. Filterable by date range and transaction type, the table exposes the direct market actions of those with the deepest knowledge of a company's operations — providing a factual, data-driven signal of internal conviction that complements traditional fundamental and technical analysis.
Transaction date | Executive | Executive Title | Security Type | Acquisition / Disposal | Shares | Share price |
|---|---|---|---|---|---|---|
| May 12, 2026 | SCHALOP, LEE TROY | Director | Common stock, $0.001 par value | Acquisition | 48,544 | $2.06 |
| May 12, 2026 | SCHALOP, LEE TROY | Director | Common stock purchase warrant (Right to Buy) | Disposal | 48,544 | $0 |
| May 12, 2026 | KEYSER, D JEFFREY | Director | Common stock purchase warrant (Right to Buy) | Disposal | 48,544 | $0 |
| May 12, 2026 | KEYSER, D JEFFREY | Director | Common stock, $0.001 par value | Acquisition | 48,544 | $2.06 |
| May 12, 2026 | KEYSER, D JEFFREY | Director | Common stock purchase warrant (Right to Buy) | Acquisition | 48,544 | $0 |
| May 12, 2026 | SCHALOP, LEE TROY | Director | Common stock purchase warrant (Right to Buy) | Acquisition | 48,544 | $0 |
| Jan 9, 2026 | CHANDRU, VIJAY | Director | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Jan 9, 2026 | MACCECCHINI, MARIA-LUISA | Director | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Jan 9, 2026 | SILBERSTEIN, DAVID S. | Director | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Jan 9, 2026 | MACCECCHINI, MARIA-LUISA | Director | Stock Option (Right to Buy) | Acquisition | 21,152 | $0 |
| Jan 9, 2026 | SCHALOP, LEE TROY | Director | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Jan 9, 2026 | KEYSER, D JEFFREY | Director | Stock Option (Right to Buy) | Acquisition | 28,844 | $0 |
| Jan 9, 2026 | CHANDRU, VIJAY | Director | Stock Option (Right to Buy) | Acquisition | 17,307 | $0 |
| Jan 9, 2026 | KEYSER, D JEFFREY | Director | Stock Option (Right to Buy) | Acquisition | 25,000 | $0 |
| Jan 9, 2026 | SCHALOP, LEE TROY | Director | Stock Option (Right to Buy) | Acquisition | 18,460 | $0 |
| Jan 9, 2026 | SILBERSTEIN, DAVID S. | Director | Stock Option (Right to Buy) | Acquisition | 17,307 | $0 |
| Dec 18, 2025 | MARGRAVE, DAVID R. | Chief Financial Officer | Stock Option (Right to Buy) | Acquisition | 20,000 | $0 |
| Dec 18, 2025 | BHATIA, KISHOR G. | Chief Scientific Officer | Stock Option (Right to Buy) | Acquisition | 10,000 | $0 |